Search Orphan Drug Designations and Approvals
-
| Generic Name: | ciprofloxacin dry powder inhaler |
|---|---|
| Date Designated: | 04/17/2014 |
| Orphan Designation: | Treatment of non-cystic fibrosis bronchiectasis |
| Orphan Designation Status: | Designated/Withdrawn |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Bayer HealthCare Pharmaceuticals, Inc. P. O. Box 1000 Montville, New Jersey 07045 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
